                               SEQUENCE LISTING

<110> ROCHE DIAGNOSTICS GMBH
      F. HOFFMANN-LA ROCHE AG
      ROCHE MOLECULAR SYSTEMS, INC.
 
<120> AN IMPROVED OLIGONUCLEOTIDE INHIBITOR OF DNA POLYMERASES

<130> P31881-WO-KOE


<150> 61/919,520
<151> 2013-12-20

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
cgatcatctc agaacattct tagcgttttg ttcttgtgta tgatcg                      46


<210> 2
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<220>
<221> source
<223> /note="Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide"

<400> 2
cgaucauctc agaacattct tagcgttttg ttcttgtgta ugaucg                      46


<210> 3
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<220>
<221> source
<223> /note="Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide"

<400> 3
cgatcatctc agaacattct tagcgtttug uucuugtgta tgatcg                      46


<210> 4
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<220>
<221> source
<223> /note="Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide"

<400> 4
cgaucauctc agaacattct tagcgtttug uucuugtgta ugaucg                      46


<210> 5
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 5
gcgctagggc gctggcaagt gtagcggtca c                                      31


<210> 6
<211> 8
<212> PRT
<213> Unknown

<220>
<221> source
<223> /note="Description of Unknown: Polymerase motif 
      peptide"

<400> 6
Asp Tyr Ser Gln Ile Glu Leu Arg 
1               5               


